AVONTEC
DEAD

Serial Number

76496366

Owner

AVONTEC GmbH

Attorney

Beate Boudro, J.D.

Filing Date

Mar 10, 2003

Add to watchlist:

No watchlists yet
View on USPTO

AVONTEC Trademark

Serial Number: 76496366

AVONTEC is a trademark filed by AVONTEC GmbH on March 10, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

AVONTEC GmbH

Humboldtallee 23
Gottingen 37073 , DE

Entity Type: 16

Trademark Details

Filing Date

March 10, 2003

Registration Date

Not Registered

Goods & Services

Educational services, namely offering seminars, workshops and symposiums in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; arranging educational conferences, and providing facilities for educational conventions

Medicaments for the treatment of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; pharmaceutical and veterinary preparations for the control of the expression of genes relevant to said diseases; preparations for diagnosis and analysis of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for medical, analytical and diagnostic purposes

Arranging and conducting business conferences

Chemical preparations, namely buffer, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, additives, polypeptides for scientific purposes; chemical preparations for the investigation and characterization of diseases, namely, of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for scientific purposes

Scientific and industrial research and consulting, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; identification of target structures for the development of medicaments, particularly polypeptides and nucleic acids; research and development of new technologies and pharmaceutical products for others, particularly for the control of the expression of genes relevant to diseases; product and technology research and development for others, namely, development of processes and products for scientific and industrial research, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; product development in the field of nucleic acids

Filing History

EXPARTE APPEAL TERMINATED
May 23, 2005 EXPT
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
May 23, 2005 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
May 13, 2005 ABN3
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
May 13, 2005 EXFB
ACTION DENYING REQ FOR RECON E-MAILED
Jan 10, 2005 GECD
ACTION CONTINUING FINAL - COMPLETED
Jan 10, 2005 CNCF
EX PARTE APPEAL-INSTITUTED
Oct 14, 2004 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 14, 2004 JURT
AMENDMENT FROM APPLICANT ENTERED
Oct 13, 2004 ACEC
EXPARTE APPEAL RECEIVED AT TTAB
Oct 12, 2004 EXAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2004 CRFA
PAPER RECEIVED
Sep 27, 2004 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2004 TCCA
FINAL REFUSAL MAILED
Mar 22, 2004 CNFR
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Mar 5, 2004 UNPR
FAX RECEIVED
Mar 5, 2004 FAXX
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2004 TROA
NON-FINAL ACTION MAILED
Aug 25, 2003 CNRT
ASSIGNED TO EXAMINER
Aug 25, 2003 DOCK